These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35698789)

  • 1. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
    Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.
    Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A
    J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretins (orexins): The ultimate translational neuropeptides.
    Jacobson LH; Hoyer D; de Lecea L
    J Intern Med; 2022 May; 291(5):533-556. PubMed ID: 35043499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
    Beuckmann CT; Yanagisawa M
    J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
    Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
    Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of orexins/hypocretins in multiple physiological functions].
    Ueta Y
    J UOEH; 2001 Jun; 23(2):147-59. PubMed ID: 11431960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the Mysteries of Sleep.
    Yanagisawa M
    Keio J Med; 2019; 68(1):27. PubMed ID: 30905886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The physiological role of orexins.
    Martynska L; Wolinska-Witort E; Chmielowska M; Bik W; Baranowska B
    Neuro Endocrinol Lett; 2005 Aug; 26(4):289-92. PubMed ID: 16135995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
    Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
    Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OX2R-selective orexin agonism is sufficient to ameliorate cataplexy and sleep/wake fragmentation without inducing drug-seeking behavior in mouse model of narcolepsy.
    Yamamoto H; Nagumo Y; Ishikawa Y; Irukayama-Tomobe Y; Namekawa Y; Nemoto T; Tanaka H; Takahashi G; Tokuda A; Saitoh T; Nagase H; Funato H; Yanagisawa M
    PLoS One; 2022; 17(7):e0271901. PubMed ID: 35867683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models.
    Irukayama-Tomobe Y; Ogawa Y; Tominaga H; Ishikawa Y; Hosokawa N; Ambai S; Kawabe Y; Uchida S; Nakajima R; Saitoh T; Kanda T; Vogt K; Sakurai T; Nagase H; Yanagisawa M
    Proc Natl Acad Sci U S A; 2017 May; 114(22):5731-5736. PubMed ID: 28507129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
    Sun Y; Tisdale RK; Kilduff TS
    Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocretin and its emerging role as a target for treatment of sleep disorders.
    Cao M; Guilleminault C
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):227-34. PubMed ID: 21170610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
    Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
    Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of orexin neuron activity in sleep/wakefulness regulation.
    Hung C; Yamanaka A
    Peptides; 2023 Jul; 165():171007. PubMed ID: 37030519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.
    Chemelli RM; Willie JT; Sinton CM; Elmquist JK; Scammell T; Lee C; Richardson JA; Williams SC; Xiong Y; Kisanuki Y; Fitch TE; Nakazato M; Hammer RE; Saper CB; Yanagisawa M
    Cell; 1999 Aug; 98(4):437-51. PubMed ID: 10481909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.